Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient

Yang, Xubo; Min, Xiaoxue; He, Weimin

doi:10.1097/md.0000000000010845

Cited by 5 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chemotherapy in long-term surviving patients also produces changes in the phenotype of malignant cells [13]. Therefore, patients diagnosed with one type of NHL, even after achieving a complete response, should be closely followed-up to detect relapses of other NHL types [14].…”

Section: Discussionmentioning

confidence: 99%

Mucosa-associated lymphoid tissue lymphoma of the parotid gland – a case report

Muntean¹,

Dudea

Lenghel

et al. 2021

Med Ultrason

View full text Add to dashboard Cite

Mucosa-associated lymphoid tissue (MALT) lymphoma of the parotid gland is a rare entity among head and neck tumours. We report a case of a patient with a medical history of diffuse large B-cell Non-Hodgkin Lymphoma with complete remission following chemotherapy, who presented seven years afterwards with a progressive painless hard swelling of the right parotidgland. Ultrasonography followed by contrast-enhanced MRI features was consistent with a malignant tumour. Consequently, fine and core needle aspiration biopsy were performed under ultrasound guidance and the final histopathological result was MALT lymphoma of the parotid gland. The most important particularity of the case is the sequential development of two different histopathological types of Non-Hodgkin Lymphoma, both of B-cell lineage.

show abstract

Section: Discussionmentioning

confidence: 99%

Mucosa-associated lymphoid tissue lymphoma of the parotid gland – a case report

Muntean¹,

Dudea

Lenghel

et al. 2021

Med Ultrason

View full text Add to dashboard Cite

show abstract

“…In addition, some literatures indicated that few MALT lymphoma transformed into diffuse large B-cell Lymphoma (DLBCL). [27,28] Qi et al [29] reported the MALT lymphoma patients with an SUV≥10 had a higher incident rate of large cell transformation and inferior overall survival (OS). The patient in this report was diagnosed as MALT lymphoma in her parotid gland, but the PET/CT findings presented as extreme invasiveness.…”

Section: Discussionmentioning

confidence: 99%

18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement

et al. 2019

View full text Add to dashboard Cite

Rationale: Mucosa-associated lymphoid tissue (MALT) lymphoma is an extranodal low-grade B cell lymphoma that generally exhibits an indolent clinical course. Currently, the application of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in MALT lymphoma is still controversial. Herein, we reported a case of using 18 F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement. As far as we know, there are no similar case reports have been published before. Patient concerns: A 71-year-old woman, who received mass resection twice during the past 2 years due to the repeatedly relapse of facial painless masses and diagnosed as reactive lymphoid hyperplasia by pathologic tests. However, the pathological diagnosis was then changed to primary parotid MALT lymphoma after left parotidectomy operation because of a new mass found in her left parotid. Four months later, the right eyelid of the patient swelled with a blurred vision. Then, 18 F-FDG PET/CT scan was performed for staging, and the imaging results showed an abnormal increase of 18 F-FDG uptake in multiple sites including bilateral ocular adnexal, lungs, pleura, occipital subcutaneous tissue, left kidney, and lymph nodes. Diagnoses: The patient was diagnosed as primary parotid MALT lymphoma with Ann Arbor stage of IVA based on the 18 F-FDG PET/CT findings. Interventions: The patient received 4 cycles of chemotherapy, followed by a partial metabolic remission (PMR), which was determined by interim 18 F-FDG PET/CT, and finally additional 2 cycles of chemotherapy. Outcomes: The follow-up study illustrated that the patient had been alive and doing well at 12 months after chemotherapy. Lessons: Although MALT lymphoma normally localizes in the primary organs, the involvement of multiple organs and lymph nodes is possible. The use of PET/CT demonstrated significant clinical values in the accurate staging and response assessment of 18 F-FDG-avid MALT lymphoma. It is potentially useful for indicating the progress and transformation of MALT lymphoma, and guidance in localization of pathological biopsy. It is also helpful for clinicians to choose reasonable treatment strategy and improve the prognosis of patients.

show abstract

Intracranial dural based marginal zone MALT-type B-cell lymphoma: a case – Based update and literature review

Rocca

Auricchio

Mazzucchi³

et al. 2021

British Journal of Neurosurgery

View full text Add to dashboard Cite

Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient

Abstract: Physicians should pay particular attention to the long-term development of other types of NHL after achieving complete remission of one type of NHL.

Cited by 5 publications

References 14 publications

Mucosa-associated lymphoid tissue lymphoma of the parotid gland – a case report

Mucosa-associated lymphoid tissue lymphoma of the parotid gland – a case report

18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement

Intracranial dural based marginal zone MALT-type B-cell lymphoma: a case – Based update and literature review

Contact Info

Product

Resources

About